Kalix Technologies develops portable molecular diagnostic systems that let farmers and veterinarians test animal, food, water, and agricultural samples on-site in about an hour. Based in Centerville, Ohio, the company combines PCR testing with automated analysis and cloud-based data tools, including a compact unit that can process up to 16 samples at once. Kalix was selected for the AgLaunch365 accelerator and received support through Ohio’s Third Frontier Technology Validation and Startup Fund.
Chembio Diagnostic Systems, IncChembio Diagnostic Systems, a Medford, New York subsidiary of Biosynex, develops and manufactures rapid point-of-care diagnostic tests for detecting and monitoring disease. Its proprietary Dual Path Platform (DPP®) technology supports simple tests that can use a small blood sample and deliver results in about 15 minutes, including the FDA-approved, CLIA-waived DPP® HIV-Syphilis test. Chembio serves clients worldwide through offices and partners and also applies its diagnostic platform to veterinary testing.MEDFORD, NY
Novel Microdevices, IncBaltimore-based Novel Microdevices develops portable, sample-to-answer molecular diagnostic systems built around disposable microfluidic cartridges. Its battery-powered Novel Dx platform is designed to deliver lab-quality PCR results in about 15 minutes, including testing for respiratory infections and other diseases at the point of care. The company is establishing a GMP-compliant pilot manufacturing facility at its Baltimore headquarters to scale cartridge production.BALTIMORE, MD
Prompt DiagnosticsBaltimore-based Prompt Diagnostics develops portable molecular diagnostic platforms that bring laboratory-quality PCR testing to the point of care, with results in under 20 minutes. Co-founded by biomedical engineer Alex Trick and Johns Hopkins professor Tza-Huei (Jeff) Wang, the company built its platform around magnetofluidic cartridge technology invented during Trick’s doctoral research. Prompt is applying that technology to infectious-disease testing, including work on HIV, syphilis, and drug-resistant gonorrhea in low-resource settings.BALTIMORE, MD
Biomeme, IncSince 2012, Biomeme has built its identity around decentralizing molecular diagnostics, developing field-ready testing for people who need biological answers outside a central laboratory. The Philadelphia company works with military and first-responder organizations as well as healthcare and research users, and makes its systems on site in a 40,000-square-foot vertically integrated facility.541714PHILADELPHIA, PA